Why Morphic Therapeutic (MORF) Stock Leapt More Than 100% Today? Here Is The Reason
The stock of biopharmaceutical company Morphic Therapeutic (Nasdaq: MORF) has been trading at an uptick of +104.98% to $74.12 in early trading today (10:55 a.m. EST). The price rise came following an announcement of positive results of an ongoing clinical study for the treatment of inflammatory bowel disease (IBD). Get the hottest stocks to trade […]
